Pernilla Videhult Pierre
Overview
Explore the profile of Pernilla Videhult Pierre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Videhult Pierre P, Fransson A, Kisiel M, Laurell G
Ann Otol Rhinol Laryngol
. 2022 Aug;
132(8):865-872.
PMID: 35962590
Objective: Molecular hydrogen (H) has shown therapeutic potential in several oxidative stress-related conditions in humans, is well-tolerated, and is easily administered via inhalation.The aim of this preclinical in vivo study...
2.
Fransson A, Videhult Pierre P, Risling M, Laurell G
Front Cell Neurosci
. 2021 Jun;
15:658662.
PMID: 34140880
Noise exposure is the most important external factor causing acquired hearing loss in humans, and it is strongly associated with the production of reactive oxygen species (ROS) in the cochlea....
3.
Videhult Pierre P, Edvardsson Rasmussen J, Aski S, Damberg P, Laurell G
Otol Neurotol
. 2020 Mar;
41(4):545-553.
PMID: 32176146
Hypothesis: Furosemide alters the permeability of the intrastrial fluid-blood barrier. Background: The cochlear sensory cells are protected by the blood-perilymph and intrastrial fluid-blood barriers, which hinder substances, including gadolinium-based contrast...
4.
Videhult Pierre P, Eklof M, Smeds H, Asp F
Audiol Neurootol
. 2019 Dec;
24(6):299-308.
PMID: 31846976
Introduction: Precurved cochlear implant (CI) electrode arrays were developed in an attempt to improve the auditory outcome of cochlear implantation, which varies greatly. The recent CI532 (Cochlear Corp., Sydney, Australia)...
5.
Pirttila K, Videhult Pierre P, Haglof J, Engskog M, Hedeland M, Laurell G, et al.
Metabolomics
. 2019 Oct;
15(10):138.
PMID: 31587113
Introduction: Noise-induced hearing loss (NIHL) is an increasing problem in society and accounts for a third of all cases of acquired hearing loss. NIHL is caused by formation of reactive...
6.
Videhult Pierre P, Fransson A, Kisiel M, Damberg P, Aski S, Andersson M, et al.
Front Cell Neurosci
. 2019 Jul;
13:268.
PMID: 31293387
Background: Middle ear (intratympanic, IT) administration is a promising therapeutic method as it offers the possibility of achieving high inner ear drug concentrations with low systemic levels, thus minimizing the...
7.
Cortes Fuentes I, Videhult Pierre P, Berglin C
Ear Hear
. 2019 May;
41(1):17-24.
PMID: 31045652
Cochlear implant surgery is a successful procedure for auditory rehabilitation of patients with severe to profound hearing loss. However, cochlear implantation may lead to damage to the inner ear, which...
8.
Fransson A, Kisiel M, Pirttila K, Pettersson C, Videhult Pierre P, Laurell G
Front Cell Neurosci
. 2017 Sep;
11:280.
PMID: 28955207
Permanent hearing loss and tinnitus as side-effects from treatment with the anticancer drug cisplatin is a clinical problem. Ototoxicity may be reduced by co-administration of an otoprotective agent, but the...
9.
Videhult Pierre P, Haglof J, Linder B, Engskog M, Arvidsson T, Pettersson C, et al.
Acta Otolaryngol
. 2017 May;
137(10):1024-1030.
PMID: 28537102
Background: Ototoxicity from treatment with the anticancer drug cisplatin remains a clinical problem. A wide range of intracellular targets of cisplatin has been found in vivo. Aim: To investigate cisplatin-induced...
10.
Berglin C, Videhult Pierre P, Ekborn A, Bramer T, Edsman K, Hultcrantz M, et al.
Acta Otolaryngol
. 2015 Jul;
135(10):985-94.
PMID: 26146023
Conclusion: A formulation based on sodium hyaluronate (NaHYA) was the most promising candidate vehicle for intra-tympanic drug administration regarding conductive hearing loss, inflammatory reactions, and elimination. Objectives: Recent advances in...